Victoria Soldatenkova Selected Research

Anthracyclines

5/2013

A randomized phase II non-comparative study of pemetrexed‑carboplatin and gemcitabine‑vinorelbine in anthracycline- and taxane-pretreated advanced breast cancer patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Victoria Soldatenkova Research Topics

Disease

15	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2023 - 05/2006
8	Disease Progression 11/2023 - 08/2012
4	Neoplasms (Cancer) 10/2023 - 01/2016
4	Breast Neoplasms (Breast Cancer) 05/2013 - 03/2005
3	Thrombocytopenia (Thrombopenia) 01/2022 - 05/2013
2	Exanthema (Rash) 01/2022 - 03/2015
2	Sarcoma (Soft Tissue Sarcoma) 01/2022 - 01/2020
2	Neutropenia 06/2016 - 05/2013
2	Adenocarcinoma 08/2012 - 11/2010
1	medullary Thyroid cancer 11/2023
1	Hypertension (High Blood Pressure) 10/2022
1	Thyroid Neoplasms (Thyroid Cancer) 10/2022
1	Fever (Fevers) 01/2022
1	Fatigue 01/2022
1	Drug Hypersensitivity (Drug Allergy) 01/2022
1	Hypersensitivity (Allergy) 01/2022
1	Arthralgia (Joint Pain) 01/2022
1	Hypotension (Low Blood Pressure) 01/2022
1	Pain (Aches) 01/2022
1	Tachycardia (Tachyarrhythmias) 01/2022
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 03/2021
1	Leiomyosarcoma 01/2020
1	Venous Thromboembolism 01/2018
1	Non-Muscle Invasive Bladder Neoplasms 09/2009
1	Transitional Cell Carcinoma 09/2009
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 07/2006
1	Wounds and Injuries (Trauma) 07/2006

Drug/Important Bio-Agent (IBA)

9	Cisplatin (Platino)FDA LinkGeneric 03/2021 - 05/2006
8	Pemetrexed (MTA)FDA Link 03/2021 - 11/2010
8	Gemcitabine FDA Link 10/2017 - 03/2005
6	selpercatinibIBA 11/2023 - 03/2021
6	necitumumabIBA 11/2019 - 03/2015
3	Phosphotransferases (Kinase)IBA 10/2023 - 01/2022
3	Carboplatin (JM8)FDA LinkGeneric 03/2021 - 05/2013
2	Alanine Transaminase (SGPT)IBA 10/2022 - 01/2022
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 10/2022 - 01/2022
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 01/2020
2	taxaneIBA 05/2013 - 03/2012
2	Docetaxel (Taxotere)FDA Link 08/2012 - 11/2010
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 08/2012 - 11/2010
2	Epirubicin (Ellence)FDA LinkGeneric 12/2008 - 03/2005
1	vandetanib (ZD6474)IBA 11/2023
1	cabozantinibIBA 11/2023
1	CreatinineIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	pembrolizumabIBA 03/2021
1	olaratumabIBA 01/2020
1	abemaciclibIBA 11/2019
1	Monoclonal AntibodiesIBA 01/2018
1	ErbB Receptors (EGF Receptor)IBA 01/2016
1	Immunoglobulin G (IgG)IBA 01/2016
1	AnthracyclinesIBA 05/2013
1	Vinorelbine (Navelbine)FDA LinkGeneric 05/2013
1	Taxoids (Taxanes)IBA 03/2012
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2008
1	Fluoxetine (Prozac)FDA LinkGeneric 07/2006
1	Fluorouracil (Carac)FDA LinkGeneric 03/2005
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 03/2005
1	Paclitaxel (Taxol)FDA LinkGeneric 03/2005

Therapy/Procedure

10	Therapeutics 10/2022 - 03/2005
5	Drug Therapy (Chemotherapy) 03/2021 - 03/2005
2	Adjuvant Chemotherapy 12/2015 - 12/2008
1	Radiotherapy 05/2013
1	Induction Chemotherapy 05/2013
1	Chemoradiotherapy 05/2013
1	Secondary Prevention 07/2006